Gilead Sciences, Inc. Appoints Dr. John J. Toole as Senior Vice President, Corporate Development

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) announced today the appointment of John J. Toole, MD, PhD, to the position of Senior Vice President, Corporate Development. In this role, Dr. Toole will be responsible for setting the strategy for and managing the company’s business development and alliance management activities. Dr. Toole will report to John F. Milligan, PhD, Gilead’s Chief Operating Officer and Chief Financial Officer.

Back to news